Home » Program

Program

icon_track_field

Schedule

[otw_shortcode_button href=”https://isobm2016congress.com/wp-content/uploads/2016/01/43rd-ISOBM-Congress-Program-Abstracts-191-236-1.pdf” size=”large” icon_type=”general foundicon-down-arrow” icon_position=”left” shape=”radius” color_class=”otw-orange”]Download ISOBM Schedule [/otw_shortcode_button]

 

Registration and Exhibition Hours for ISOBM 2017

 

Location: Rendezvous Area

 

Registration Hours:

Wednesday, August 31: 3:00 PM – 9:00 PM

Thursday, September 1: 8:00 AM – 4:00 PM

Friday, September 2: 8:00 AM – 5:00 PM

Saturday, September 3: 8:00 AM – 4:00 PM

Sunday, September 4: 8:00 AM – 5:00 PM

Monday, September 5: 8:00 AM – 5:00 PM

Tuesday, September 6: 8:00 AM – 11:00 AM

 

Exhibition Hours:

[Vendor Setup: Wednesday, August 31, 9:00AM – 3:00PM]

Wednesday, August 31: 3:00 PM – 9:00 PM

Thursday, September 1: 8:00 AM – 4:00 PM

Friday, September 2: 8:00 AM – 5:00 PM

Saturday, September 3: 8:00 AM – 4:00 PM

Sunday, September 4: 8:00 AM – 5:00 PM

Monday, September 5: 8:00 AM – 5:00 PM

Tuesday, September 6: 9:00 AM – 1:30 PM

 

DAY ONE (Thursday, September 1st)

Grant Park Room

8:00 AM – 11:45 AM ISOBM Board Meeting
11:45 AM – 12:45 PM Student Orientation

 

Gold Room

Opening Ceremony

1:00 PM – 1:08 PM Welcome Video
1:08 PM – 1:13 PM Welcome & Opening Remarks Dr. James Radosevich, Congress President
1:13 PM – 1:16 PM Star Spangled Banner Megan McLaughlin
1:16 PM – 1:20 PM Illinois State Anthem Megan McLaughlin
1:20 PM – 1:25 PM Welcome Remarks Dr. Robert Barish, Vice Chancellor for Health Affairs, University of Illinois at Chicago
1:25 PM – 1:30 PM Introduction of Elliott Gunmaker & Ho Chunk Drummers Dr. James Radosevich, Congress President
1:30 PM – 1:50 PM Ho Chunk Drummers Performance

 

Rendevzous Area

1:50 PM – 2:00 PM Coffee Break


 

Gold Room

Keynote Presentations

Introductions: Dr. B. Aydogan (USA)

2:00 PM – 3:00 PM Targeting DNA Repair in Oncology Dr. P. Connell
3:00 PM – 4:00 PM Title TBA Dr. C. Croce
4:00 PM – 4:05 PM Closing Remarks Dr. James Radosevich, Congress President

 

Signature Room at the John Hancock Building

Opening Reception

5:45 PM VIPs meet at front entrance of hotel to board bus to Hancock Building
6:15 PM VIP bus arrives at Hancock Building
6:25 PM Attendees meet at front entrance of hotel to board buses to Hancock Building
6:45 PM First attendees arrive at Hancock Building — Receiving line at the Hancock Building on the 95th Floor Set Up (VIPs/ Board members)
7:00 PM – 9:30 PM Reception at the Hancock Building
9:30 PM – 10:00 PM Buses back to the Congress Hotel

 

 

 

 

DAY TWO (Friday, September 2nd)

Florentine Room

Scientific Session: Early Cancer Detection

Chairpersons: Dr. I. Cree (UK), Dr. C. Chapman (UK), Dr. A. Murray (UK)

8:00AM – 8:20AM Plasma cfDNA for Early Cancer Detection Dr. I. Cree
8:20AM – 8:40AM Autoantibodies in Lung Cancer Detection Dr. C. Chapman
8:40AM – 9:00AM Improvement in Performance of the EarlyCDT-Lung Test for Detection of Lung Cancer by Addition of Antigenic Biomarkers Dr. A. Murray
9:00AM – 9:20AM Lung Cancer Screening Initiative with Cuba Dr. K. Tossas-Milligan
9:20AM – 9:40AM A Novel Serological Marker for Pancreatic Cancer Dr. K. Taniuchi
9:40AM – 10:00AM Abbott ARCHITECT® AFP and PIVKA II for Early Detection of Hepatocellular Carcinoma Dr. P. Hemken

 

Gold Room

Scientific Session: Breast Cancer Biomarkers & Oncogenes

Chairpersons: Dr. V. Barak (Israel), Dr. H. Batool (Dubai), Dr. R. Molina (Spain)

8:00 AM – 8:30 AM Serum HER-2 as a Sensitive Tumor Marker in Breast Cancer Patients Dr. V. Barak
8:30 AM – 9:00 AM Immunotherapy in Endocrine Dependent Metastatic Breast Cancer Dr. A. Nicolini
9:00 AM – 9:20 AM Mutant p53 as a New Therapeutic Target for Breast Cancer Treatment Dr. M.J. Duffy
9:20 AM – 9:40 AM Circulating Levels of HER-2/neu Oncoprotein in Breast Cancer: Clinical Utility as Tumor Marker and in Therapy Monitoring Dr. R. Molina
9:40 AM – 10:00 AM Round Table Discussion

 

Rendevzous Area

10:00 AM – 10:30 AM Coffee Break

 

Florentine Room

Scientific Session: Tumor Hypoxia for Prediction of Response & Cancer Prognosis

Chairpersons: Dr. H. Halpern (USA), Dr. B. Aydogan (USA), Dr. B. Clifford (USA)

10:30AM – 11:00AM Tumor Hypoxia for Prediction of Response and Cancer Prognosis Dr. H. Halpern
11:00AM – 11:20AM Towards Oxygen-Guided Radiation Therapy Validation in Mice Model Dr. B. Epel
11:20AM – 11:40AM Using Electron Paramagnetic Resonance (EPR) to Identify Hypoxic Microenvironments in Tumors Expressing Hypoxia-Induced Proteins Dr. R. Miller
11:40AM – 12:00PM Imaging Transient Hypoxia in Tumors Using Fast Low-Rank Tensor Based EPR Imaging with Physical Priors Dr. B. Clifford

 

Gold Room

Scientific Session: Imaging as Biomarkers in Oncology

Chairpersons: Dr. B. Aydogan (USA)

10:30 AM – 10:50 AM Imaging as Cancer Biomarker for Diagnosis, Targeting, and Treatment Response Dr. B. Aydogan
10:50 AM – 11:25 AM X-ray Absorption, Fluorescence, and Luminescence as Potential Cancer Biomarkers Dr. P. LaRiviere
11:25 AM – 12:00 PM Advanced Diffusion MRI Techniques for Cancer Diagnosis and Treatment Monitoring Dr. J. Zhou

 

Plaza/Belmont/Francis I

12:00 PM – 12:45 PM Lunch

 

Gold Room

Keynote Presentations

Introductions: Dr. V. Barak (Israel), Dr. R. Molina (Spain)

12:45 PM – 1:45 PM Liver Cancer and Liver Cancer Biomarkers Dr. J. Marrero
1:45 PM – 2:30 PM Title TBA Dr. R. Bikkavilli
2:30 PM – 3:15 PM Oral Microbiome as Biomarkers for Head and Neck Cancers Dr. J. Schwartz

 

Rendevzous Area

3:15 PM –  3:30 PM Coffee Break

 

Florentine Room

Scientific Session: Circulating Cancer Cells & Biomarkers

        Chairpersons: Dr. S. Holdenrieder (Germany), Dr. J. Borgia (USA), Dr. L. Feldman (USA)

3:30 PM – 4:00 PM Serum biomarkers associated with disease progression in non-small cell lung cancer Dr. J. Borgia
4:00 PM – 4:20 PM Title TBA Dr. L. Feldman
4:20 PM – 4:40 PM The Effect of p85-sHER3 on Cancer Cell Growth and Migration: Requirement for Tenascin-C Dr. S.K. Rajpurohit

 

Gold Room

Scientific Session: Targeted Cancer Therapies & Stem cell

Chairpersons: Dr. J. Radosevich (USA), Dr. J. Chowdhury (USA), Dr. J. LaBelle (USA)

3:30 PM – 3:45 PM Nitric Oxide on Cancer Stem Cells Dr. J. Radosevich
3:45 PM – 4:00 PM Massive Oval (Stem) Cell Proliferation in Livers of Genetically Altered Mice after Aflatoxin Exposure Dr. S. Sell
4:00 PM – 4:15 PM Reactivation of Cancer Cell Death Using Novel Peptide Based Therapeutics Dr. J. LaBelle
4:15 PM – 4:30 PM IGF­1R Blockades for Gastrointestinal Cancer Cells with Mutated K­ras Gene Dr. Y. Adachi
4:30 PM – 4:45 PM Selected Growth Factors and Different Gastric Neoplasms in Humans Dr. B. Wojciech
4:45 PM – 5:00 PM A Rat Model for Nanoparticle Directed Treatment and Prevention of Liver Cancer Dr. S. Sell
5:00 PM – 5:15 PM Carboxypeptidase M (Cpm) Contributes Tumor Growth and Metastasis Related in Epithelial Mesenchymal Transition in Human Esophageal Carcinoma Dr. K. Kato


Poster Presentations at University of Illinois at Chicago (UIC), College of Dentistry

6:00PM Poster presenters/VIPs meet at front entrance of hotel to board bus to UIC
6:15PM Attendees meet at front entrance of hotel to board bus to UIC
6:30 PM – 9:30 PM Poster Session & Chicago Deep Dish Style Pizza

 

 

 

DAY THREE (Saturday, September 3rd)

Florentine Room

Scientific Session: Upper Respiratory Biology & Biomarkers

Chairpersons: Dr. L. Feldman (USA), Dr. P. Bonomi (USA), Dr. Jeff Borgia (USA)

8:00 AM – 8:45 AM Molecular Markers in Non-Small Cell Lung Cancer Dr. P. Bonomi
8:45 AM – 9:30 AM Validation of an Algorithm Using Tumor Markers, Clinical Data, and Imagine Techniques to Help in the Diagnosis and Histological Diagnosis of Lung Cancer Dr. R. Molina
9:30 AM – 9:45 AM Serial Tumor Marker Determination in Therapy Monitoring of Small Cell Lung Cancer Patients Dr. S. Holdenreider
9:45 AM – 10:00 AM Transcriptomic and Methylome Approaches to Identify Genetic Alterations in Esophageal Cancer of India Dr. I. Chattopadhyay

 

Gold Room

Scientific Session: Current Issues in Gastrointestinal & Gynecological Cancer

Chairpersons: Dr. M.J. Duffy (Ireland), Dr. L. Feldman (USA), Dr. K. Batool (USA)

8:00 AM – 8:15 AM Differential Levels of Hypoxia-Induced Factor-1a and 2a in Hepatocellular Carcinomas Dr. G. Chen
8:15 AM – 8:30 AM The Combination of uPAR(I) and Type IV Collagen Outperforms CEA as a Prognostic Biomarker in Primary Colorectal Cancer Dr. I. Christensen
8:30 AM – 8:45 AM Colorectal Cancer Associated Biomarkers: The Effect of Bowel Preparation Dr. N. Pedersen
8:45 AM – 9:00 AM Increased Serological Protein Biomarker Levels at Diagnostic Bowel Endoscopy Are Associated with Risk of Being Diagnosed with Subsequent Primary Malignancy Dr. T. Piper
9:00 AM – 9:15 AM Glad-PCR Assay of DNA Methylation Markers Associated with Colorectal Cancer Dr. A. Evdokimov
9:15 AM – 9:30 AM Prototype Biomarker Panel Algorithms for Aiding in Early Colorectal Cancer (CRC) Detection Dr. G. Davis
9:30 AM – 9:45 AM A Reflex Algorithm for Identifying Presence of Extra-Colonic Cancers in False-Positive CRC Screened Subjects Dr. S. Gawel
9:45 AM – 10:00 AM Epigenetic Profiling of Circulating Cell Free Nucleosomes: A Novel Approach to Reducing the Impact of Colorectal Cancer Dr. M. Eccleston
10:15AM – 10:30AM Biomarker & Early Detection of Ovarian Cancer Dr. A. Barua

 

Rendevzous Area

10:15 AM – 10:30 AM Coffee Break

 

Florentine Room

Session Title: Targeted Immunotherapies

Chairpersons: Dr. M. Chechlinska (Poland), Dr. J. Labelle (USA)

10:30AM – 10:45AM Deletion of DNA-Binding Inhibitor Id3 Enhances Anticancer Function of T Cells by Inducing Th9 Cells Dr. D. Zhang
10:45AM – 11:00AM An Anti-PSMA Immunotoxin Induces Apoptosis and Efficiently Eliminates Prostate Cancer Cells in Combination with ABT-737 Dr. M. Michalska

 

Gold Room

Scientific Session: Liquid Biopsies and Serum Assays

Chairpersons: Dr. C. Mandal (India), Dr. Borgia (USA), Dr. Thomas (USA)

10:30 AM – 10:45 AM Targeting Cellular Cholesterol Might Be a Therapeutic Strategy for Breast Cancer Bone Metastasis Dr. C. Mandal
10:45 AM- 11:00 AM Early Detection of Neoplasia Dr. M. Wilhelmsen

 

Gold Room

Keynote Presentation

Introduction: Dr. C. Maki (USA)

11:00AM – 12:00PM Evolving Role of Precision Medicine to Guide Decision Making in Oncology Dr. A. Dudek

 

Plaza/Belmont/Francis I

12:00 PM – 12:45 PM Lunch

Gold Room

Keynote Presentations

Introductions: R. Molina (Spain), V. Barak (Israel)

12:45 PM – 1:45 PM Discovery of Cyclic GMP and Nitric Oxide in Cell Signaling and Their Role in Drug Development Dr. F. Murad
1:45 PM – 2:30 PM Vitamin D Receptor and Cancer Dr. M. Kadakia
2:30 PM – 3:00 PM Title TBA Dr. G. Adami

 

Rendevzous Area

3:00 PM –  3:15 PM Coffee Break

 

Florentine Room

Scientific Session: Circulating Tumor Nucleosomes, DNA & Genetics

Chairpersons: Dr. S. Holderieder (Germany), Dr. E. Yoruker (Turkey), Dr. S. Sell (USA)

3:15 PM – 3:30 PM Circulating Cell Free Nucleosome Levels Are Not Affected by Stage of CRC, Comorbidity or Demographic Variables Dr. L. Rasmussen
3:30 PM – 3:45 PM Targeted Exome Sequencing of Cancer-Related Genes in Human Cancers Using the Semiconductor Sequencer Dr. Y. Sasaki
3:45 PM – 4:00 PM Phenothiazines Modulate Chromatin-Related DNA Repair Signaling in Tumors Dr. P. Hååg
4:00 PM – 4:15 PM Significance Estimation of EGFR and Their Polymorphisms in Non-Small Cell Lung Cancer Dr. V. Jurisic

 

Gold Room

Session Title: Hot Topics in Cancer Research

Chairpersons: Dr. Malaiyanda (USA), Dr. Patel (India), Dr. J. Chowdhury (USA)

3:15 PM – 3:30 PM Diagnostic Value of Interleukin-31and 33 in Endometrial Cancer Dr. Xi Zeng
3:30 PM – 3:45 PM Biopsy Levels of miR-375, miR-200b and miR-29c Associated with Prognosis of Head and Neck Cancers Dr. Jaromir Gumulec
3:45 PM – 4:00 PM The Role of Human DNA Repair Protein APE1/Ref-1 in Transcriptional Regulation of Genes Involved in Cancer Development Dr. Milena Bazlekowa
4:00 PM – 4:15 PM Anticancer Effects Elicited by Combination of Rubus Extract with Phthalocyanine Photosensitiser on MCF-7 Cells Dr. G. Blassan

 

Odyssey Boat Cruise at Navy Pier

5:00 PM Meet at front entrance of hotel to board bus to Navy Pier
7:00 PM Last boarding of ship
7:00 PM – 11:00 PM Lake Michigan Dinner / Dance Cruise
11:00 PM- 12:00 AM Buses back to hotel

 

 

 

DAY FOUR (Sunday, September 4th)

Florentine Room

Session Title: Clinical Applications of Cancer Biomarkers

Chairpersons: Dr. Sanchez-Carbayo (Spain), Dr. R. Molina (Spain), Dr. H. Batool (USA)

8:30 AM – 9:00 AM HE4 a New Tumor Marker in Ovarian Cancer: Controversies and Clinical Applications Dr. R. Molina
9:00 AM – 9:15AM Soluble Epha2 Has a Potential of Novel Serum Biomarker for Malignant Cancers Dr. T. Kondo
9:15 AM – 9:30 AM Protocol: Detection of False FIT Negative Subjects by Combinations of Blood-Based Biomarkers Dr. H. Nielsen
9:30 AM – 9:45 AM PMF-1 Methylation Is a Prognostic and Predictive Biomarker of Sunitinib Response in Patients with Kidney Cancer Dr. M. Sánchez-Carbayo
9:45 AM – 10:00 AM Diagnostic Performance of Tumor Makers AFP and PIVKA-II in Chinese Hepatocellular Carcinoma Patients Dr. X. Wang

 

Gold Room

Session Title: Tumor Immunology

            Chairpersons: Dr. Nicolini (Italy), Dr. Malaiyandi (USA), Dr. Nap (Netherlands)

8:30 AM – 8:45 AM MicroRNAs as Molecular Markers in Central Nervous System Lymphomas Dr. M. Chechlinska
8:45 AM – 9:00 AM Investigation of Putative Molecular Marker in Human Papillomavirus Associated Cervical Cancer in Indian Population Dr. M. Bharadwaj
9:00 AM – 9:15 AM Evaluation of an Improved Version of the Arocell TK 210 ELISA for Determining TK1 Protein Levels In Serum Samples Dr. K. Jagarlamudi
9:15 AM – 9:30 AM Human Papillomavirus, an Oncogenic SUMO Wrestler Dr. A. Nag
9:30 AM – 9:45 AM Investigation of Snps/Haplotypes as Biomarkers to Tobacco Associated Oral Squamous Cell Carcinoma in Indian Population Dr. M. Bharadwaj
9:45 AM – 10:00 AM The Influence of PSA Autoantibodies in Prostate Cancer Dr. K. Nakajima

 

Rendevzous Area

10:00 AM – 10:30 AM Coffee Break

 

Gold Room

Session Title:  Current Topics in Liver & Pancreatic Carcinomas

            Chairpersons: Dr. Bassiony (Egypt), Dr. De Vitto (Brazil), Dr. Nag (India)

10:30 AM – 10:45 AM A Novel Biomarker for Early Diagnosis of Hepatocellular Carcinoma Dr. N. Koshikawa
10:45 AM – 11:00 AM Cytokine Induction by Trabedersen (OT-101) Treatment: Results from a Phase I/II Trial in Pancreatic Cancer Patients Dr. L. Hwang

 

Gold Room

Keynote Presentation

Introduction: Dr. Malaiyandi (USA)

11:00 AM – 12:00 PM Botanicals as Natural Alternatives to Hormone Replacement Therapy: Role in Breast Cancer Prevention? Dr. J. Bolton

 

Plaza/Belmont/Francis I

12:00 PM – 1:00 PM Lunch

 

Gold Room

Keynote Presentation

Introduction: Dr. K. Dineley (USA)

1:00 PM – 2:00 PM Wnt5a Modulates Vascularization of Non-Small Cell Lung Cancer Dr. J. Pongracz

 

Rendevzous Area

2:00 PM –  2:30 PM Coffee Break

 

Gold Room

Scientific Session: European Group on Tumour Markers (EGTM)

Chairpersons: Dr. V. Barak (Israel), Dr. R. Molina (Spain), Dr. J. Radosevich (USA)

2:30 PM – 3:00 PM The Clinical Role of the Immune Biomarker sIL2R in Head and Neck Cancer Dr. V. Barak
3:00 PM – 3:30 PM Biomarkers in Colorectal Cancer: Which Ones are Clinically Useful? Dr. M.J. Duffy
3:30 PM – 4:00 PM Tumor Markers Use for the Differential Diagnostic of Effusions Dr. R. Molina &

Dr. Trape

4:00 PM – 4:30 PM Biomarkers: Best Assays to Assess Response to New Therapies and Provide Prognosis in Melanoma Patients Dr. V. Barak

 

Plaza/Belmont/Francis I

4:30 PM – 6:00 PM Hor D’oeuvers

 

Gold Room

6:00 PM – 8:00 PM General Assembly (Chaired by Dr. R. Molina)

 

 

DAY FIVE (Monday, September 5th)

Gold Room

Session Title: New Models in Cancer Research

Chairpersons: Dr. K. Batul (Dubai), Dr. C. Chapman (UK), Dr. C. Maki (USA)

9:00 AM – 9:30 AM Diabetes, metformin and oral precancer progression Dr. A. Schneider
9:30 AM – 10:00 AM Computational simulation models containing NSCLC patient genomic signatures predict drug responder status to anti-PD-1 immunotherapy Dr. K. Brogden
10:00 AM – 10:30 AM Using Pseudomonas Exotoxin T (ExoT) to target apoptotic compensatory proliferation signaling in cancer Dr. S. Shafikhani

 

Rendevzous Area

10:30 AM –  11:00 AM Coffee Break

 

Gold Room

Keynote Presentation

Introduction: Dr. S. Holdenreider (Germany)

11:00AM – 12:00PM Mechanism-Based Repurposing of Neurodegenerative Disease Drugs for Breast Cancer Treatment Dr. A. Rana

 

Plaza/Belmont/Francis I

12:00 PM – 1:00 PM Lunch

 

Gold Room

Keynote Presentations

Introductions: Dr. R. Molina (Spain), Dr. V. Barak (Israel), Dr. Patel (India), Dr. Borgia (USA)

1:00 PM – 2:00 PM Developing Precision Medicine for Lung Cancer Dr. J. Minna
2:00 PM – 2:30 PM Title TBA Dr. R. Winn
2:30 PM – 3:00 PM Cold Environment Is a Risk Factor for Cancer Dr. C. Mandal

 

Rendevzous Area

3:00 PM –  3:30 PM Coffee Break

 

Gold Room

Session Title: Mechanisms and Development of New Cancer Agents

Chairpersons: Dr. M.J. Duffy (Ireland), Dr. C. Maki (USA), Dr. J. Chowdhury (USA)

3:30 PM – 3:45 PM Crosstalk Between p53 and the IGF-IR/AKT mTORCI Pathway Reduces the Effectiveness of IGF-IR Dr. C. Maki
3:45 PM – 4:00 PM TPS an Appropriate Marker for the Follow-up Monitoring of Breast Cancer Patients After Radical Surgery Dr. R. Kucera

 

Rendevzous Area

7:00 PM –  11:00 PM Gala Dinner

 

DAY SIX (Tuesday, September 6th)

Grant Park Room

8:00AM – 9:00AM Executive ISOBM Board Meeting

 

Florentine Room

Scientific Session:  Biomarkers in Prostate Cancer

Chairpersons: Dr. R. Szmulewitz (USA)

9:00 AM – 9:30 AM Hox Protein Regulators as Biomarkers in Prostate Cancer Dr. D. Vander Griend
9:30 AM – 10:00 AM Molecular Biomarkers in Castration Resistant Prostate Cancer: What We Learn From the Blood Dr. R. Szmulewitz

 

Rendevzous Area

10:00 AM –  10:30 AM Coffee Break

 

Florentine Room

Scientific Session:  Radiomics & Radiogenomics as Biomarkers in Precision Medicine

Chairpersons: Dr. B. Aydogan (USA), Dr. H. Li (USA)

10:30AM – 11:00AM Radiomics of Breast Cancer and Associated Challenges with Big Data Dr. K. Drukker
11:00AM – 11:30AM Radiomics in Breast Cancer Risk Assessment Dr. H. Li
11:30AM – 11:45AM Deep Learning in the Radiomics of Breast Cancer Imaging Dr. B. Huynh

 

Florentine Room

12:00 PM – 12:30 PM Closing Ceremony

 

Plaza/Belmont/Francis I

12:30 PM – 1:30 PM Hor D’oeuvers

 

Grant Park Room

1:30 PM Executive ISOBM Board Meeting

Floor Plan 

[pdf-embedder url=”https://isobm2016congress.com/wp-content/uploads/2016/01/Congress-Plaza-floorplan.pdf”]

[pdf-embedder url=”https://isobm2016congress.com/wp-content/uploads/2016/01/43rd-ISOBM-Congress-Program-Abstracts-191-236-1.pdf”]